TKTill Kaireit

Till Kaireit

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Till Kaireit has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early post-transplant ventilation and perfusion assessment using phase-resolved functional lung MRI

    by Marc-Luca Heinze, Fabio Ius, Andreas Voskrebenzev, Till Kaireit, Marius Klein, Arjang Ruhparwar, Jawad Salman, Frank Wacker, Jens Vogel-Claussen, Gesa H. Pöhler

    Purpose: Post-transplant functional lung surveillance relies on global ventilatory assessment using spirometry, lacking regional ventilation and perfusion measures. We aimed to assess early post-transplant lung function in clinically stable recipients using phase-resolved functional lung (PREFUL) MRI. Material and methods: In this prospective, single-center study (March 2022–December 2024), clinically stable bilateral lung transplant recipients and 1:1 age- (± 5 years) sex-matched participants ( n = 100) underwent PREFUL MRI and spirometry. Ventilation and perfusion MRI was voxel-based quantified: Regional ventilation (RVent, [mL/mL]), flow-volume loop ventilation (FVL, [au]) and perfusion (Q, [mL/min/100 mL]). Whole lung defect maps (VDP, QDP [%]), V/Q ratios (%) based on RVent, FVL and Q were generated. Median MRI parameters were compared with controls, spirometry and perioperative data (Bonferroni correction P<.0045 considered significant). Results: 84 participants (42 transplant recipients and 42 healthy participants) were evaluated at median 16 days post-transplantation. In lung transplant recipients RVent, FVL and Q did not differ from controls (all P  > 0.01). Transplant recipients demonstrated increased RVent VDP (10% vs 3.7%, P  < 0.001), VDP combined (14% vs 7.1%, P  < 0.001) and QDP (7.9% vs 2.4%, P  < 0.001). In transplant recipients FVL, FVL VDP, QDP and V/Q matched defects correlated with spirometry. QDP was associated with prolonged cold ischemic times of first lung allografts ( ρ = 0.43, P = 0.004), V/Q mismatch with cold ischemic times of first and second implanted lungs ( ρ = 0.48, P = 0.001; ρ = 0.46, P  = 0.002). Conclusion: Free-breathing phase-resolved functional lung MRI-derived parameters revealed increased regional ventilation and perfusion heterogeneity in stable lung transplant recipients two weeks post-transplantation and correlated with spirometry and prolonged cold ischemic times of allografts.

  • Open Access

    Acute and 14-day effects of tiotropium/olodaterol on cardiopulmonary function in COPD

    by Thomas Kayser, Nadja Struß, René Pflock, Karsten Heusser, Agilo L. Kern, Andreas Voskrebenzev, Lea Behrendt, Till F. Kaireit, Philipp Badorrek, Jens Tank, et al.

    Background: Lung hyperinflation in COPD adversely affects cardiac function and may influence autonomic nervous system activity. The onset of cardiac improvement with dual bronchodilator therapy remains uncertain. Methods: In this randomised, placebo-controlled, investigator-blinded, mechanistic, single-dose crossover trial with an open-label 2-week extension we assessed tiotropium/olodaterol (T/O) effects on cardiopulmonary function and muscle sympathetic nerve activity (MSNA) in hyperinflated COPD patients. 32 participants received saline (placebo) and T/O (5 µg/5 µg) in a crossover design, followed by 14 days of open-label T/O. The primary end-point was change in left ventricular end-diastolic volume index (LV-EDVi) measured by magnetic resonance imaging (MRI). Secondary assessments included pulmonary function tests, MSNA measurements and advanced lung imaging including 129 Xe-MRI. Findings: Single-dose T/O significantly increased LV-EDVi relative to placebo (3.25 mL·m −2 ; 95% CI 0.95 to 5.56), driven partly by a decrease under placebo. Compared with baseline, T/O's acute LV-EDVi gain was minimal, yet it reached significance at 14 days (4.70 mL·m −2 ; 95% CI 1.75 to 7.65). Pulmonary parameters, in contrast, showed immediate improvement, with a marked reduction in residual volume (−0.67 L; 95% CI −0.82 to −0.51) after a single dose. MSNA demonstrated a nonsignificant numerical rise post single-dose T/O. No serious adverse events occurred. Interpretation: T/O rapidly improves pulmonary function in hyperinflated COPD patients, but significant cardiac benefits seem to require sustained therapy. These results underscore the importance of continued dual bronchodilator therapy to achieve cardiovascular improvements. The nonsignificant rise in MSNA after a single dose suggests minimal immediate effect on sympathetic activity; further studies are necessary to evaluate long-term autonomic outcomes.


  • Predicting Pulmonary Graft Loss Using Oxygen-enhanced MRI T1 Mapping in a Prospective Study

    by Milan Speth, Till F. Kaireit, Marcel Gutberlet, Filip Klimeš, Lea Behrendt, Andreas Voskrebenzev, Frank Wacker, Jens Gottlieb, Jens Vogel-Claussen

    Oxygen-enhanced MRI mapping parameters predicted chronic lung allograft dysfunction–related graft loss in lung transplant recipients when measured 6–12 months after transplant.

  • PREFUL MRI for Monitoring Perfusion and Ventilation Changes after Elexacaftor-Tezacaftor-Ivacaftor Therapy for Cystic Fibrosis: A Feasibility Study

    by Martha Dohna, Andreas Voskrebenzev, Filip Klimeš, Till F. Kaireit, Julian Glandorf, Sophia T. Pallenberg, Felix C. Ringshausen, Gesine Hansen, Diane Miriam Renz, Frank Wacker, et al.

    Purpose To assess the feasibility of monitoring the effects of elexacaftor-tezacaftor-ivacaftor (ETI) therapy on lung ventilation and perfusion in people with cystic fibrosis (CF), using phase-resolved functional lung (PREFUL) MRI. Materials and Methods This secondary analysis of a multicenter prospective study was carried out between August 2020 and March 2021 and included participants 12 years or older with CF who underwent PREFUL MRI, spirometry, sweat chloride test, and lung clearance index assessment before and 8-16 weeks after ETI therapy. For PREFUL-derived ventilation and perfusion parameter extraction, two-dimensional coronal dynamic gradient-echo MR images were evaluated with an automated quantitative pipeline. T1- and T2-weighted MR images and PREFUL perfusion maps were visually assessed for semiquantitative Eichinger scores. Wilcoxon signed rank test compared clinical parameters and PREFUL values before and after ETI therapy. Correlation of parameters was calculated as Spearman ρ correlation coefficient. Results Twenty-three participants (median age, 18 years [IQR: 14-24.5 years]; 13 female) were included. Quantitative PREFUL parameters, Eichinger score, and clinical parameters (lung clearance index = 21) showed significant improvement after ETI therapy. Ventilation defect percentage of regional ventilation decreased from 18% (IQR: 14%-25%) to 9% (IQR: 6%-17%) (P = .003) and perfusion defect percentage from 26% (IQR: 18%-36%) to 19% (IQR: 13%-24%) (P = .002). Areas of matching normal (healthy) ventilation and perfusion increased from 52% (IQR: 47%-68%) to 73% (IQR: 61%-83%). Visually assessed perfusion scores did not correlate with PREFUL perfusion (P = .11) nor with ventilation-perfusion match values (P = .38). Conclusion The study demonstrates the feasibility of PREFUL MRI for semiautomated quantitative assessment of perfusion and ventilation changes in response to ETI therapy in people with CF. Keywords: Pediatrics, MR-Functional Imaging, Pulmonary, Lung, Comparative Studies, Cystic Fibrosis, Elexacaftor-Tezacaftor-Ivacaftor Therapy, Fourier Decomposition, PREFUL, Free-Breathing Proton MRI, Pulmonary MRI, Perfusion, Functional MRI, CFTR, Modulator Therapy, Kaftrio Clinical trial registration no. NCT04732910 Supplemental material is available for this article. © RSNA, 2024.


  • Open Access

    Comparison of Free‐Breathing 3D Phase‐Resolved Functional Lung (PREFUL) MRI With Dynamic 19F Ventilation MRI in Patients With Obstructive Lung Disease and Healthy Volunteers

    by Filip Klimeš, Arnd J. Obert, Julienne Scheller, Marius M. Wernz, Andreas Voskrebenzev, Marcel Gutberlet, Robert Grimm, Hendrik Suhling, Robin A. Müller, Till F. Kaireit, et al.

    Background: Non‐contrast‐enhanced 1H magnetic resonance imaging (MRI) with full lung coverage shows promise for assessment of regional lung ventilation but a comparison with direct ventilation measurement using 19F MRI is lacking.Purpose: To compare ventilation parameters calculated using 3D phase‐resolved functional lung (PREFUL) MRI with 19F MRI.Study Type: Prospective.Population: Fifteen patients with asthma, 14 patients with chronic obstructive lung disease, and 13 healthy volunteers.Field Strength/Sequence: A 3D gradient‐echo pulse sequence with golden‐angle increment and stack‐of‐stars encoding at 1.5 T.Assessment: All participants underwent 3D PREFUL MRI and 19F MRI. For 3D PREFUL, static regional ventilation (RVent) and dynamic flow‐volume cross‐correlation metric (FVL‐CM) were calculated. For both parameters, ventilation defect percentage (VDP) values and ventilation defect (VD) maps (including a combination of both parameters [VDPCombined]) were determined. For 19F MRI, images from eight consecutive breaths under volume‐controlled inhalation of perfluoropropane were acquired. Time‐to‐fill (TTF) and wash‐in (WI) parameters were extracted. For all 19F parameters, a VD map was generated and the corresponding VDP values were calculated.Statistical Tests: For all parameters, the relationship between the two techniques was assessed using a Spearman correlation (r). Differences between VDP values were compared using Bland–Altman analysis. For regional comparison of VD maps, spatial overlap and Sørensen–Dice coefficients were computed.Results: 3D PREFUL VDP values were significantly correlated to VDP measures by 19F (r range: 0.59–0.70). For VDPRVent, no significant bias was observed with VDP of the third and fourth breath (bias range = −6.8:7.7%, P range = 0.25:0.30). For VDPFVL‐CM, no significant bias was found with VDP values of fourth–eighth breaths (bias range = −2.0:12.5%, P range = 0.12:0.75). The overall spatial overlap of all VD maps increased with each breath, ranging from 61% to 81%, stabilizing at the fourth breath.Data Conclusion: 3D PREFUL MRI parameters showed moderate to strong correlation with 19F MRI. Depending on the 3D PREFUL VD map, the best regional agreement was found to 19F VD maps of third–fifth breath.Level of Evidence: 3Technical Efficacy: Stage 2


  • Phase-resolved Functional Lung (PREFUL) MRI–derived Ventilation and Perfusion Parameters Predict Future Lung Transplant Loss

    by Jens Vogel-Claussen, Till F. Kaireit, Andreas Voskrebenzev, Filip Klimeš, Julian Glandorf, Lea Behrendt, Marcel Gutberlet, Christopher Korz, Milan Speth, Tobias Welte, et al.

    Background Chronic lung allograft dysfunction (CLAD), the physiologic correlate of chronic rejection, remains a major barrier to long-term survival following lung transplant. Biomarkers for early prediction of future transplant loss or death due to CLAD might open a window of opportunity for early diagnosis and treatment of CLAD. Purpose To evaluate the prognostic use of phase-resolved functional lung (PREFUL) MRI in predicting CLAD-related transplant loss or death. Materials and Methods In this prospective, longitudinal, single-center study, PREFUL MRI-derived ventilation and parenchymal lung perfusion parameters of bilateral lung transplant recipients without clinically suspected CLAD were assessed 6-12 months (baseline) and 2.5 years (follow-up) after transplant. MRI scans were acquired between August 2013 and December 2018. Regional flow volume loop (RFVL)-based ventilated volume (VV) and perfused volume were calculated using thresholds and spatially combined as ventilation-perfusion (V/Q) matching. Spirometry data were obtained on the same day. Exploratory models were calculated using receiver operating characteristic analysis, and subsequent survival analyses (Kaplan-Meier, hazard ratios [HRs]) of CLAD-related graft loss were performed to compare clinical and MRI parameters as clinical end points. Results At baseline MRI examination, 132 clinically stable patients of 141 patients (median age, 53 years [IQR, 43-59 years]; 78 men) were included (nine were excluded for deaths not associated with CLAD), 24 of which had CLAD-related graft loss (death or retransplant) within the observational period of 5.6 years. PREFUL MRI-derived RFVL VV was a predictor of poorer survival (cutoff, 92.3%; log-rank P = .02; HR for graft loss, 2.5 [95% CI: 1.1, 5.7]; P = .02), while perfused volume (P = .12) and spirometry (P = .33) were not predictive of differences in survival. In the evaluation of percentage change at follow-up MRI (92 stable patients vs 11 with CLAD-related graft loss), mean RFVL (cutoff, 97.1%; log-rank P < .001; HR, 7.7 [95% CI: 2.3, 25.3]), V/Q defect (cutoff, 498%; log-rank P = .003; HR, 6.6 [95% CI: 1.7, 25.0]), and forced expiratory volume in the first second of expiration (cutoff, 60.8%; log-rank P < .001; HR, 7.9 [95% CI: 2.3, 27.4]; P = .001) were predictive of poorer survival within 2.7 years (IQR, 2.2-3.5 years) after follow-up MRI. Conclusion Phase-resolved functional lung MRI ventilation-perfusion matching parameters were predictive of future chronic lung allograft dysfunction-related death or transplant loss in a large prospective cohort who had undergone lung transplant. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Fain and Schiebler in this issue.


  • Open Access

    Volume‐Controlled 19F MR Ventilation Imaging of Fluorinated Gas

    by Arnd J. Obert, Agilo L. Kern, Marcel Gutberlet, Andreas Voskrebenzev, Till F. Kaireit, Cristian Crisosto, Mark Greer, E. Tobias Krause, Frank Wacker, Jens Vogel‐Claussen

    Background: 19F MRI of inhaled gas tracers has developed into a promising tool for pulmonary diagnostics. Prior to clinical use, the intersession repeatability of acquired ventilation parameters must be quantified and maximized.Purpose: To evaluate repeatability of static and dynamic 19F ventilation parameters and correlation with predicted forced expiratory volume in 1 second (FEV1%pred) with and without inspiratory volume control.Study Type: Prospective.Population: A total of 30 healthy subjects and 26 patients with chronic obstructive pulmonary disease (COPD).Field Strength/Sequence: Three‐dimensional (3D) gradient echo pulse sequence with golden‐angle stack‐of‐stars k‐space encoding at 1.5 T.Assessment: All study participants underwent 19F ventilation MRI over eight breaths with inspiratory volume control (w VC) and without inspiratory volume control (w/o VC), which was repeated within 1 week. Ventilated volume percentage (VVP), fractional ventilation (FV), and wash‐in time (WI) were computed. Lung function testing was conducted on the first visit.Statistical Tests: Correlation between imaging and FEV1%pred was measured using Pearson correlation coefficient (r). Differences in imaging parameters between first and second visit were analyzed using paired t‐test. Repeatability was quantified using intraclass correlation coefficient (ICC) and coefficient of variation (CoV). Minimum detectable effect size (MDES) was calculated with a power analysis for study size n = 30 and a power of 0.8. All hypotheses were tested with a significance level of 5% two sided.Results: Strong and moderate linear correlations with FEV1%pred for COPD patients were found in almost all imaging parameters. The ICC w VC exceeds the ICC w/o VC for all imaging parameters. CoV was significantly lower w VC for initial VVP in COPD patients, FV, CoV FV, WI and standard deviation (SD) of WI. MDES of all imaging parameters were smaller w VC.Data Conclusion: 19F gas wash‐in MRI with inspiratory volume control increases the correlation and repeatability of imaging parameters with lung function testing.Evidence Level: 2Technical Efficacy: Stage 2


  • Open Access

    PREFUL MRI Depicts Dual Bronchodilator Changes in COPD: A Retrospective Analysis of a Randomized Controlled Trial

    by Andreas Voskrebenzev, Till F. Kaireit, Filip Klimeš, Gesa H. Pöhler, Lea Behrendt, Heike Biller, Korbinian Berschneider, Frank Wacker, Tobias Welte, Jens M. Hohlfeld, et al.

    Indacaterol-glycopyrronium improves ventilation, perfusion, and ventilation-perfusion match in patients with chronic obstructive pulmonary disease measured by phase-resolved functional lung (PREFUL... Purpose To assess whether dynamic ventilation and perfusion (Q) biomarkers derived by phase-resolved functional lung (PREFUL) MRI can measure treatment response to 14-day therapy with indacaterol-g...


  • Open Access

    Comparison of dual-energy computer tomography and dynamic contrast-enhanced MRI for evaluating lung perfusion defects in chronic thromboembolic pulmonary hypertension

    by Tawfik Moher Alsady, Till F. Kaireit, Lea Behrendt, Hinrich B. Winther, Karen M. Olsson, Frank Wacker, Marius M. Hoeper, Serghei Cebotari, Jens Vogel-Claussen

    Objectives: To evaluate the agreement in detecting pulmonary perfusion defects in patients with chronic thromboembolic pulmonary hypertension using dual-energy CT and dynamic contrast-enhanced MRI. Second, to compare both imaging modalities in monitoring lung perfusion changes in these patients after undergoing pulmonary endarterectomy. Methods: 20 patients were examined with CT and MRI before and/or after pulmonary endarterectomy. Estimated perfusion defect percentage from both modalities was compared in a lobe-based analysis. Spatial agreement of perfusion defect maps was also assessed. Results: A significant correlation between CT and MRI based perfusion defect percentage was calculated in all lung lobes (r > 0.78; p < 0.001). In addition, a good spatial agreement between perfusion defect maps was found (mean spatial overlap for the whole lung was 68.2%; SD = 6.9). Both CT and MRI detected improvements in pulmonary perfusion after pulmonary endarterectomy: 8% and 7% decrease in whole lung perfusion defect percentage (p = 0.007 and 0.004), respectively. In a lobe-wise analysis, improvements were statistically significant only in lower lobes using both modalities (reduction in defect percentage ranged from 16–29%; p < 0.02). Conclusions: Dual-energy CT is an alternative to MRI in monitoring chronic thromboembolic pulmonary hypertension. Both imaging modalities provided comparable estimations of perfusion defects and could detect similar improvement in lung perfusion after pulmonary endarterectomy.


  • Open Access

    Flow Volume Loop and Regional Ventilation Assessment Using Phase‐Resolved Functional Lung (PREFUL) MRI: Comparison With 129Xenon Ventilation MRI and Lung Function Testing

    by Till F Kaireit, Agilo Kern, Andreas Voskrebenzev, Gesa H Pöhler, Filip Klimes, Lea Behrendt, Marcel Gutberlet, Tawfik Moher‐Alsady, Anna‐Maria Dittrich, Frank Wacker, et al.

    Background: Regional flow volume loop ventilation‐weighted noncontrast‐enhanced proton lung MRI in free breathing has emerged as a novel technique for assessment of regional lung ventilation, but has yet not been validated with 129Xenon MRI (129Xe‐MRI), a direct visualization of ventilation in healthy volunteers, cystic fibrosis (CF), and chronic obstructive pulmonary disease (COPD) patients.Purpose: To compare regional ventilation and regional flow volume loops measured by noncontrast‐enhanced ventilation‐weighted phase‐resolved functional lung MRI (PREFUL‐MRI) with 129Xe‐MRI ventilation imaging and with lung function test parameters.Study Type: Retrospective study.Population: Twenty patients with COPD, eight patients with CF, and six healthy volunteers.Field Strength/Sequence: PREFUL and 129Xe‐MRI gradient echo sequences were acquired at 1.5T.Assessment: Coronal slices of PREFUL‐MRI (free breathing) and 129Xe‐MRI (single breath‐hold) were acquired on the same day, matched by their ventrodorsal position and coregistered for evaluation. Ventilation defect percentage (VDP) was calculated based on regional ventilation (RV), regional flow volume loops (RFVL), or 129Xe‐MRI with two different threshold methods. A combined VDP was calculated for RV and RFVL. Additionally, lung function testing was performed (such as the forced expiratory volume in 1 second [FEV1]) was used.Statistical Tests: The obtained parameters were compared using Wilcoxon tests, correlated using Spearman's correlation coefficient (r), and agreement between PREFUL and 129Xe‐MRI parameters was assessed using Bland–Altman analysis and Dice coefficients.Results: VDP measured by PREFUL and 129Xe were significantly correlated with both thresholding techniques (r = 0.62–0.69, P < 0.05 for all) and with lung function test parameters. Combined RV and RFVL PREFUL defect maps correlated with lung function testing (eg, with FEV1 r = –0.87 P < 0.05), and showed better regional agreement to 129Xe‐MRI ventilation defects (Dice coefficient defect 0.413) with significantly higher VDP values (10.2 ± 27.3, P = 0.04) than either PREFUL defect map alone.Data Conclusion: Combined RV and RFVL PREFUL defect maps likely increase sensitivity to mild airway obstruction with increased VDP values compared to 129Xe‐MRI, and correlate strongly with lung function test parameters.Level of Evidence: 3Technical Efficacy Stage: 2